|
|
Other links at Articles > Allergy and Clinical Immunology |
| 1. |
Rituximab May Treat Severe Atopic Eczema: Pilot Study
|
|
|
In a pilot study of patients with severe treatment-refractory atopic eczema, depletion of B cells by monoclonal anti-CD20 antibody therapy (rituximab) led to "an impressive improvement" in atopic eczema symptoms, reduced skin inflammation and normalization of skin architecture, clinicians from Switzerland found. Reuters Health Information
|
|
|